Semaglutide, tirzepatide, and the next wave
What the class does well, common side effects, real-world adherence, compounding issues, and why the evidence is stronger here than almost anywhere else.
Noterad 2026 EditionThePeptideField Guide
The honest, evidence-based companion to GLP-1 medications, recovery peptides, growth hormone secretagogues, gray-market sourcing, clinics, costs, regulation, and the risks most sales pages skip.
$39
instant digital access
No subscription. No clinic pitch. Built as a reference for adults who want clarity before they make decisions.
28
parts covering the full peptide landscape
6
appendices with glossary, tables, labs, and checklists
2026
edition calibrated to the current market
$39
saved during the sale from the $78 regular price
Why this matters
The peptide market moved faster than most people can verify.
GLP-1s became mainstream medicine. Recovery and anti-aging peptides became internet products. Telehealth clinics and research-chemical vendors turned a complex medical category into a checkout flow. This guide brings the evidence, risks, and regulatory reality back into view.
1
Separate approved medicine from gray-market hype.
Understand which peptides have strong clinical evidence, which are experimental, and which are sold far beyond the data.
2
Read claims through an evidence hierarchy.
The book distinguishes FDA-approved use, human trials, limited clinical data, animal-only research, and marketing claims.
3
Spot quality, contamination, and sourcing risk.
Compounded products, research chemicals, cold-chain handling, sterility, endotoxins, and third-party testing all get practical attention.
4
Evaluate clinics and costs with a clear head.
Premium clinic pricing, telehealth scripts, subscription models, and cheaper alternatives are compared without pretending every option is equal.
Inside the e-book
A complete field guide for a contested category.
Use it once as a full read, then keep it as a reference when a peptide, clinic, stack, or claim shows up in your feed.
BPC-157, TB-500, GHK-Cu, KPV
The injury and recovery peptides get a sober review of mechanisms, animal data, limited human evidence, regulatory status, and practical risk.
Secretagogues and growth signaling
Sermorelin, ipamorelin, CJC-1295, MK-677, IGF-1 analogues, and the cost-benefit gap between modest effects and aggressive marketing.
Quality, contamination, and legality
Research chemicals, compounding rules, FDA Category 2 concerns, international variation, import risk, sterility, endotoxin exposure, and source verification.
Sexual function, cognition, skin, hair, performance
PT-141, semax, selank, epitalon, MOTS-c, cosmetic peptides, muscle claims, WADA concerns, and where the data thins out.
Clinics, labs, interactions, and who should avoid use
How to evaluate providers, what labs can and cannot tell you, stacking risks, contraindications, monitoring logic, and harm-reduction checklists.
Field guide format
Built for adult decisions, not miracle claims.
The guide is direct about uncertainty. Strong evidence gets labeled strong. Weak evidence gets labeled weak. Gray-market risk gets treated as a real risk, not a footnote.
- Use quick-reference sections when evaluating a specific peptide.
- Compare approved, compounded, and research-chemical channels.
- Check the evidence level before believing a before-and-after story.
- Review labs, interactions, contraindications, and athletic eligibility.
From the guide
"Peptides are neither miracle nor menace."
The book uses that frame throughout: serious about legitimate medicine, skeptical of grift, and explicit about the uncertainty around unapproved compounds.
Evidence hierarchy
FDA-approved use, human trials, clinical evidence, animal data, and marketing are kept separate.
Reference tables
Major peptides summarized by class, regulatory status, evidence level, and common use.
Clinic evaluation
Telehealth, premium peptide clinics, compounding claims, price signals, and red flags.
Harm reduction
Checklists for baseline thinking, monitoring, warning signs, and gray-market caution.
What you get
A cleaner way to navigate a noisy market.
This is for readers who want a premium, skeptical, evidence-aware reference before spending clinic money, ordering from a gray-market source, or trusting an influencer stack.
01
Know what is proven
GLP-1s and approved prescription peptides are treated differently from claims based on early or animal-only evidence.
02
Know what is uncertain
The guide names the long-term unknowns, thin evidence, and unstudied combinations that marketing tends to smooth over.
03
Know what can go wrong
Quality, contamination, sterility, interactions, contraindications, cost, legal exposure, and athletic rules are handled directly.
04
Know what to ask
Use the book to pressure-test a clinic, a protocol, a vendor, a social-media claim, or your own assumptions.
Sale offer
Get The Peptide Field Guide today for $39.
Regular price is $78. The launch sale gives you the complete 2026 edition with the full guide, peptide reference table, regulatory overview, lab-test appendix, source list, and harm-reduction checklist.
Complete digital e-book
28 main parts
6 practical appendices
Instant checkout access
Questions
Before you buy
Is this medical advice?
No. The guide is educational and cannot replace a clinician who knows your history. It is designed to help you understand the category, ask better questions, and recognize risk.
Does the book recommend using peptides?
No. It explains what peptides are, where the evidence is strong or weak, what risks matter, and how different categories are regulated. Coverage does not mean endorsement.
Is it only about GLP-1 medications?
No. GLP-1s receive deep coverage, but the book also covers BPC-157, TB-500, GHK-Cu, KPV, secretagogues, PT-141, cognitive peptides, performance peptides, skin and hair peptides, clinics, and sourcing.
Who is this for?
Adults evaluating peptide claims, considering a prescription conversation, comparing clinic offers, researching gray-market risks, or trying to understand the peptide landscape without marketing distortion.
Will it help me choose a clinic?
It gives you evaluation criteria, red flags, pricing context, source-quality questions, and risk categories to ask about. It does not certify or endorse specific providers.
Why buy now?
The current sale price is $39 instead of $78. If peptides are already on your radar, the cost of one unclear clinic consult or one bad product decision can exceed the price of the guide.
Medical and legal notice: This e-book is an educational guide, not a prescription, not medical advice, and not a recommendation to use any substance. Many peptides discussed in the guide are not approved for human use by the FDA, EMA, or comparable agencies. Work with a qualified clinician before considering prescription peptide medications.
Make your peptide decisions with evidence in front of you.
Get the complete 2026 field guide for $39 while the sale is live.
Get the Peptide Guide — $39